Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and olopatadine hydrochloride

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with olopatadine hydrochloride in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(olopatadine hydrochloride)
Trials
(olopatadine hydrochloride)
Recent Studies (post-2010) (olopatadine hydrochloride)
9,156187552317103111

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikemura, T; Ishii, H; Kitamura, S; Ohmori, K; Sasaki, Y1
Ikemura, T; Ishii, H; Kase, H; Kitamura, S; Manabe, H; Miki, I; Ohmori, K; Onuma, K; Sasaki, Y; Sato, S1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and olopatadine hydrochloride

ArticleYear
[Effect of KW-4679, a novel antiallergic drug, on platelet-activating factor (PAF)-induced bronchoconstriction, airway hyperresponsiveness and pulmonary cell accumulation in guinea pigs].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 106, Issue:5

    Topics: Animals; Anti-Allergic Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Dibenzoxepins; Guinea Pigs; Ketotifen; Leukocyte Count; Male; Olopatadine Hydrochloride; Platelet Activating Factor; Rabbits

1995
KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
    International archives of allergy and immunology, 1996, Volume: 110, Issue:1

    Topics: Acetyltransferases; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Autacoids; Dibenzoxepins; Enzyme Activation; Eosinophils; Guinea Pigs; Humans; Leukotriene B4; Lipids; Lipoxygenase Inhibitors; Male; Neutrophils; Olopatadine Hydrochloride; Platelet Activating Factor; Thromboxane B2; Thromboxane-A Synthase

1996